Susquehanna International Group, LLP Immunic, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Immunic, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 193,769 shares of IMUX stock, worth $228,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,769

Previous 132,450 46.3%

Holding current value

$228,647

Previous $174,000 23.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.98 - $1.44 $60,092 - $88,299	61,319 Added 46.3%	193,769 $215,000
Q1 2024 May 07, 2024	SELL	$1.14 - $1.53 $230,853 - $309,829	-202,503 Reduced 60.46%	132,450 $174,000
Q4 2023 Feb 14, 2024	BUY	$0.97 - $1.6 $99,271 - $163,747	102,342 Added 44.0%	334,953 $502,000
Q3 2023 Nov 14, 2023	SELL	$1.35 - $2.87 $35,407 - $75,274	-26,228 Reduced 10.13%	232,611 $341,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $2.51 $118,457 - $223,555	89,066 Added 52.46%	258,839 $649,000
Q1 2023 May 16, 2023	SELL	$1.35 - $2.87 $44,325 - $94,233	-32,834 Reduced 16.21%	169,773 $252,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $10.8 $204,349 - $1.95 Million	180,840 Added 830.8%	202,607 $283,000
Q3 2022 Nov 14, 2022	SELL	$3.0 - $5.49 $78,051 - $142,833	-26,017 Reduced 54.45%	21,767 $69,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $109,124 - $427,084	34,864 Added 269.85%	47,784 $166,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $238,604 - $356,656	-25,011 Reduced 65.94%	12,920 $146,000
Q2 2021 Aug 11, 2021	SELL	$11.76 - $16.85 $239,080 - $342,560	-20,330 Reduced 34.89%	37,931 $465,000
Q1 2021 May 17, 2021	BUY	$14.21 - $25.3 $443,792 - $790,144	31,231 Added 115.54%	58,261 $929,000
Q4 2020 Feb 16, 2021	BUY	$14.8 - $20.37 $89,850 - $123,666	6,071 Added 28.97%	27,030 $413,000
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $246,058 - $461,098	20,959 New	20,959 $389,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56M

Call Options Held

4.7K

Put Options Held

311K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Immunic, Inc. Transaction History